Abstract:Cell Biology InternationalVolume 32, Issue 3 p. S5-S5 The KRAB domain-containing zinc finger protein ZNF382 is a potent tumor suppressor with frequent epigenetic inactivation in nasopharyngeal, esophageal and other carcinomas Ying Duan Cheng, Ying Duan Cheng Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorYan Bai, Yan Bai Key Lab of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, ChinaSearch for more papers by this authorAda H.Y. Wong, Ada H.Y. Wong Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorPei Liang, Pei Liang Key Lab of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, ChinaSearch for more papers by this authorJi Sheng Li, Ji Sheng Li Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorJian Ming Ying, Jian Ming Ying Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorYa Cao, Ya Cao Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, ChinaSearch for more papers by this authorAnthony T.C. Chan, Anthony T.C. Chan Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorXiu Shan Wu, Xiu Shan Wu Key Lab of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, ChinaSearch for more papers by this authorQian Tao, Qian Tao Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this author Ying Duan Cheng, Ying Duan Cheng Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorYan Bai, Yan Bai Key Lab of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, ChinaSearch for more papers by this authorAda H.Y. Wong, Ada H.Y. Wong Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorPei Liang, Pei Liang Key Lab of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, ChinaSearch for more papers by this authorJi Sheng Li, Ji Sheng Li Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorJian Ming Ying, Jian Ming Ying Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorYa Cao, Ya Cao Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, ChinaSearch for more papers by this authorAnthony T.C. Chan, Anthony T.C. Chan Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this authorXiu Shan Wu, Xiu Shan Wu Key Lab of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, ChinaSearch for more papers by this authorQian Tao, Qian Tao Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong KongSearch for more papers by this author First published: 02 January 2013 https://doi.org/10.1016/j.cellbi.2008.01.026AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume32, Issue3March 2008Pages S5-S5 RelatedInformation

Phosphoproteomics Analysis of Transformation Potential of the Epstein‐barr Virus‐encoded Latent Membrane Protein 1 in Nasopharyngeal Epithelial Cells NP69

The Ubiquitination of P53 Regulated by Epstein‐barr Virus Encoded Latent Membrane Protein 1

Proteome analysis of the transformation potential of the Epstein–Barr virus-encoded latent membrane protein 1 in nasopharyngeal epithelial cells NP69

Stat3 Induced by Epstein-Barr Virus Latent Membrane Protein 1 Causes Vascular Endothelial Growth Factor Expression and Cellular Invasiveness Via Jak3 and Erk1/2 Signaling

Aspirin Induces Lytic Cytotoxicity in Epstein‐Barr Virus‐positive Cells

The Krab Domain-Containing Zinc Finger Protein Znf382 is A Potent Tumor Suppressor with Frequent Epigenetic Inactivation in Nasopharyngeal, Esophageal and Other Carcinomas

Identification of disregulated cell cycle pathway in nasopharyngeal carcinoma by gene set enrichment analysis

Dual regulation of LMP1‐augmented kappa light chain expression and secretion in nasopharyngeal carcinoma cells by NFκB and AP‐1

Activation of the Mapk Signaling Pathway in HCV NS3 Transformed Hepatocyte

Identification of Candidate Molecular Markers of Nasopharyngeal Carcinoma by Microarray Analysis of Subtracted Cdna Libraries Constructed by Suppression Subtractive Hybridization

LMP1 Regulates Op18/stathmin Signalling Pathway by Cdc2 Mediation in Nasopharyngeal Carcinoma Cells

LTF, a candidate tumor suppressor gene in metastatic nasopharyngeal carcinoma at 3p21.3, inhibits proliferation of nasopharyngeal carcinoma cells in vitro by modulating the mitogen‐activated protein kinase pathway

EXPRESSION AND CLINICAL SIGNIFICANCE OF DNA-PK IN NASOPHARYNGEAL CARCINOMA

Functional proteomics analysis of components of signaling pathways triggered by Epstein-Barr virus-encoded oncoprotein latent membrane protein 1 via novel phosphoprotein enrichment

The Nuclear Chaperone Nucleophosmin Escorts an Epstein-Barr Virus Nuclear Antigen to Establish Transcriptional Cascades for Latent Infection in Human B Cells.

Transcriptional regulation of survivin by p53 mediated by EBV‐LMP

Cells in G 2 /M Phase Increased in Human Nasopharyngeal Carcinoma Cell Line by EBV-LMP1 Through Activation of NF- Κ B and AP-1

Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.

The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.

Phosphorylation Of P53 Protein Triggered By Epstein-Barr Virus Latent Membrane Protein 1 In The Carcinogenesis Of Nasopharyngeal Carcinoma

Nuclear Translocation of EGF Receptor Regulated by Epstein-Barr Virus Encoded Latent Membrane Protein 1